Profound Medical Adds Cook Medical Channel for U.S. TULSA-PRO Sales
TORONTO – October 31, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) has signed a supply and distribution agreement with the iMRI Division of Cook Medical, adding a second U.S. capital equipment channel for its TULSA-PRO system while keeping recurring treatment kit and service revenue in-house.
Cook buys systems at a predetermined transfer price and resells them in the U.S.
Cook will purchase TULSA-PRO systems from Profound at a predetermined transfer price for U.S. distribution. Customers who buy through Cook will source single-use disposables and service contracts directly from Profound. The company therefore keeps the recurring revenue relationship on every system Cook places.
Profound's existing capital sales team will keep selling TULSA-PRO directly to sites with compatible MRI systems. The two channels target different buyers: hospitals using existing MRI infrastructure and those investing in new iMRI capabilities.